[Wegener's granulomatosis].
Kajiyama
Hiroshi
H
Institute of Rheumatology, Tokyo Women's Medical University.
Terai
Chihiro
C
D000367:Age Factors; D019268:Antibodies, Antineutrophil Cytoplasmic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007564:Japan / Q000453:epidemiology; D008297:Male; D009017:Morbidity; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D012015:Reference Standards; D012737:Sex Factors; D015996:Survival Rate; D013997:Time Factors
D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone